Risk of innovation is a big driver of high drug costs

Developing new drugs is a high-stakes gamble. National Institutes of Health data shows that more than 95% of drugs fail during development, and only about 12% of new drug applications earn Food and Drug Administration approval. Drug development is complex, expensive and competitive. The public remains concerned about the rising cost of drugs. While many